145 related articles for article (PubMed ID: 26146542)
1. Akt-mediated phosphorylation controls the activity of the Y-box protein MSY3 in skeletal muscle.
De Angelis L; Balasubramanian S; Berghella L
Skelet Muscle; 2015; 5():18. PubMed ID: 26146542
[TBL] [Abstract][Full Text] [Related]
2. Akt phosphorylation is not sufficient for insulin-like growth factor-stimulated myogenin expression but must be accompanied by down-regulation of mitogen-activated protein kinase/extracellular signal-regulated kinase phosphorylation.
Tiffin N; Adi S; Stokoe D; Wu NY; Rosenthal SM
Endocrinology; 2004 Nov; 145(11):4991-6. PubMed ID: 15489316
[TBL] [Abstract][Full Text] [Related]
3. A highly conserved molecular switch binds MSY-3 to regulate myogenin repression in postnatal muscle.
Berghella L; De Angelis L; De Buysscher T; Mortazavi A; Biressi S; Forcales SV; Sirabella D; Cossu G; Wold BJ
Genes Dev; 2008 Aug; 22(15):2125-38. PubMed ID: 18676817
[TBL] [Abstract][Full Text] [Related]
4. Akt1 and Akt2 differently regulate muscle creatine kinase and myogenin gene transcription in insulin-induced differentiation of C2C12 myoblasts.
Sumitani S; Goya K; Testa JR; Kouhara H; Kasayama S
Endocrinology; 2002 Mar; 143(3):820-8. PubMed ID: 11861503
[TBL] [Abstract][Full Text] [Related]
5. Ankyrin repeat and suppressor of cytokine signaling (SOCS) box-containing protein (ASB) 15 alters differentiation of mouse C2C12 myoblasts and phosphorylation of mitogen-activated protein kinase and Akt.
McDaneld TG; Spurlock DM
J Anim Sci; 2008 Nov; 86(11):2897-902. PubMed ID: 18641171
[TBL] [Abstract][Full Text] [Related]
6. PI3 kinase regulation of skeletal muscle hypertrophy and atrophy.
Glass DJ
Curr Top Microbiol Immunol; 2010; 346():267-78. PubMed ID: 20593312
[TBL] [Abstract][Full Text] [Related]
7. PKR is a novel functional direct player that coordinates skeletal muscle differentiation via p38MAPK/AKT pathways.
Alisi A; Spaziani A; Anticoli S; Ghidinelli M; Balsano C
Cell Signal; 2008 Mar; 20(3):534-42. PubMed ID: 18164587
[TBL] [Abstract][Full Text] [Related]
8. Constitutive expression of the orphan receptor, Rev-erbA alpha, inhibits muscle differentiation and abrogates the expression of the myoD gene family.
Downes M; Carozzi AJ; Muscat GE
Mol Endocrinol; 1995 Dec; 9(12):1666-78. PubMed ID: 8614403
[TBL] [Abstract][Full Text] [Related]
9. Dual promoter structure of ZFP106: regulation by myogenin and nuclear respiratory factor-1.
Grasberger H; Ye H; Mashima H; Bell GI
Gene; 2005 Jan; 344():143-59. PubMed ID: 15656981
[TBL] [Abstract][Full Text] [Related]
10. TFE3 inhibits myoblast differentiation in C2C12 cells via down-regulating gene expression of myogenin.
Naka A; Iida KT; Nakagawa Y; Iwasaki H; Takeuchi Y; Satoh A; Matsuzaka T; Ishii KA; Kobayashi K; Yatoh S; Shimada M; Yahagi N; Suzuki H; Sone H; Yamada N; Shimano H
Biochem Biophys Res Commun; 2013 Jan; 430(2):664-9. PubMed ID: 23211595
[TBL] [Abstract][Full Text] [Related]
11. YB-1 gene expression is kept constant during myocyte differentiation through replacement of different transcription factors and then falls gradually under the control of neural activity.
Kobayashi S; Tanaka T; Moue M; Ohashi S; Nishikawa T
Int J Biochem Cell Biol; 2015 Nov; 68():1-8. PubMed ID: 26279143
[TBL] [Abstract][Full Text] [Related]
12. Myogenin is a positive regulator of MEGF10 expression in skeletal muscle.
Park SY; Yun Y; Kim MJ; Kim IS
Biochem Biophys Res Commun; 2014 Aug; 450(4):1631-7. PubMed ID: 25044114
[TBL] [Abstract][Full Text] [Related]
13. PGC-1alpha gene expression is down-regulated by Akt- mediated phosphorylation and nuclear exclusion of FoxO1 in insulin-stimulated skeletal muscle.
Southgate RJ; Bruce CR; Carey AL; Steinberg GR; Walder K; Monks R; Watt MJ; Hawley JA; Birnbaum MJ; Febbraio MA
FASEB J; 2005 Dec; 19(14):2072-4. PubMed ID: 16203862
[TBL] [Abstract][Full Text] [Related]
14. Folic acid promotes the myogenic differentiation of C2C12 murine myoblasts through the Akt signaling pathway.
Hwang SY; Kang YJ; Sung B; Kim M; Kim DH; Lee Y; Yoo MA; Kim CM; Chung HY; Kim ND
Int J Mol Med; 2015 Oct; 36(4):1073-80. PubMed ID: 26310574
[TBL] [Abstract][Full Text] [Related]
15. Localization of MyoD, myogenin and cell cycle regulatory factors in hypertrophying rat skeletal muscles.
Ishido M; Kami K; Masuhara M
Acta Physiol Scand; 2004 Mar; 180(3):281-9. PubMed ID: 14962010
[TBL] [Abstract][Full Text] [Related]
16. Nuclear exclusion of forkhead box O and Elk1 and activation of nuclear factor-kappaB are required for C2C12-RasV12C40 myoblast differentiation.
De Alvaro C; Nieto-Vazquez I; Rojas JM; Lorenzo M
Endocrinology; 2008 Feb; 149(2):793-801. PubMed ID: 17962350
[TBL] [Abstract][Full Text] [Related]
17. Expression of insulin-like growth factor II (IGF-II), IGF binding protein-2 and myogenin during differentiation of myogenic satellite cells derived from the turkey.
Ernst CW; McFarland DC; White ME
Differentiation; 1996 Oct; 61(1):25-33. PubMed ID: 8921582
[TBL] [Abstract][Full Text] [Related]
18. Regulation of myogenin expression in normal and transformed myogenic cell lines.
Arnold HH; Braun T; Bober E; Buchberger A; Winter B; Salminen A
Symp Soc Exp Biol; 1992; 46():37-51. PubMed ID: 1341049
[TBL] [Abstract][Full Text] [Related]
19. Expression of myogenic regulatory factors during muscle development of Xenopus: myogenin mRNA accumulation is limited strictly to secondary myogenesis.
Nicolas N; Gallien CL; Chanoine C
Dev Dyn; 1998 Nov; 213(3):309-21. PubMed ID: 9825866
[TBL] [Abstract][Full Text] [Related]
20. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
